Open AccessMeta-analysis of gemcitabine and cisplatin combination chemotherapy versus gemcitabine alone for pancreatic cancer
Author(s) -
Gaojian Luo,
Diyu Huang,
Jie Fang
Publication year - 2016
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.191616
Subject(s) - gemcitabine , medicine , neutropenia , pancreatic cancer , chemotherapy , oncology , odds ratio , confidence interval , combination chemotherapy , cisplatin , survival rate , gastroenterology , anemia , cancer
The aim of this study is to assess the efficacy and safety of combination chemotherapy with gemcitabine (GEM) and cisplatin (CIS) compared with GEM alone in patients with pancreatic cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom